Activity

debra smeal - November 18 VIEW RECORDING - 17 mins (No highlights): https://fathom.video/share/2D3DghxoEvECSzyXmHxTSTQ_VuRwx_5w --- 0:00 - Andrew Hartmann (UTAK Laboratories) Hi, how are you? I'm doing lovely, thank you. 0:05 - Smeal, Debra A (brownhealth.org) We have, we're just, Andrew, we're just waiting for one more person to join us. He should be in this room any second. It's Kyle. He replaced, he's working in the same area that Mark Santangini used to work as. Oh, okay. 0:21 - Andrew Hartmann (UTAK Laboratories) Did Mark move on? Mark left us. Okay. 0:25 - Smeal, Debra A (brownhealth.org) He went to do a, um, like a service rep position. I feel like I've been working with him for a long time now. You have, and he just wanted to make a change, and part of it was hours and child care. 0:42 - Andrew Hartmann (UTAK Laboratories) get it. Yeah, yeah, yeah. 0:44 - Smeal, Debra A (brownhealth.org) So, this kid, Mark, I mean, Kyle, um, is doing largely what Mark is doing, but he doesn't have the title as yet, and unclear whether he will be awarded the title, but for now, he's my best expert on this topic. Perfect. Kim Piver, I've invited to join us because I'm going to step away from this role in January. And so I'm trying to be seamless in what I do with Kim so that she can easily just transition into this role. Lovely. 1:16 - Andrew Hartmann (UTAK Laboratories) I'll be your dedicated account manager as well. So I'll be able to work with your team, you know, consistently to make sure that we smooth over anything. Okay. 1:24 - Smeal, Debra A (brownhealth.org) So here's Kim and Kyle. 1:30 - Andrew Hartmann (UTAK Laboratories) Hey, everybody. Hello. How doing? Okay. Well, appreciate you guys making some time. So we received your PO and initially it just caused a couple of questions because like the part information on there wasn't very clear. But looking at the pricing, it looked like you guys were looking for one of our two levels of our stock amphetamine control. Is that right? Yes. That's correct. Level two. Yes. Level two. Okay. That is helpful. So essentially trolled. We have discontinued. I'm doing I'm show Those amphetamines as a stock product here at UTAK. So we're no longer making new lots as like off the shelf available to be ordered. That's for one and two. One and two, yes. Level one, I do still have some inventory on hand. Level two, I've only got two packs on hand and they expire at the end of next month. So not likely worthwhile pursuing. But what we do now is we transition it to a custom product. So instead of you guys buying something off the shelf, we're going to make it directly for you at the time of order. I was taking a look at your volume of what you guys have been historically ordering, and it looks like you guys use about 15 packs of the level one each year and about 13 packs of the level two each year. Does that sound about accurate to you? I mean, we're all new with this, though. Yeah. 2:54 - Smeal, Debra A (brownhealth.org) Yeah, the thing about with amphetamines at this point is we actually use a good amount. I out. 4:01 - Andrew Hartmann (UTAK Laboratories) Okay, because pricing with Customs, just to be transparent, is in large part based on volume. Like, if you guys were just trying to order, like, a one or two pack, it is going to be significantly more than what the stock price was. But with the 30-year shelf life, what we usually recommend is to hit, like, a two-year order volume. So for, like, level one, I'd be recommending about a 30-pack order volume, and level two would be about a 26-pack order volume. Do you use the same amount of level one and level two? I'm not really sure why there was that difference, but adding it up? 4:34 - Smeal, Debra A (brownhealth.org) No, I mean, they're both, it depends if people have issues, but no, it's both of those, like I said, it's two CCs per QC, and people usually like to make a front end and a back end, so that's four. So, and we always need to have two of those QCs now. The thing we are kind of moving to, which... Which might semi-negate some of this is, I mean, one, we want to move this away from the GCMS, so it's kind of a whole different story. But we're also really just quantitating amphetamine and methamphetamine at this point. So, like, actual quantitation of all the other amines that we have in this panel, is it super, like, necessary to be precise? We just need to say, we see it. And that's good enough for us to do our qualitative resulting, say, ephedrine or pseudoephedrine, as long as it's on our QC, so... So you just need qualitative, are there or not there? Right, correct. And so I would actually have to check with my director or even with these guys for CAP stuff, because typically if we're resulting a patient, especially quantitatively, you need two QCs, but if... we're just resulting in qualitatively, I'd be interested in the question, but a negative or a positive. So that would make us really like, this actually is kind of interesting, would be helpful because now if we're getting this personally made, we could get, so amphetamine 1 would be a certain concentration. Let's just say we're keeping it at 350. Amphetamine panel 2 would stay at the same concentration, so 700. But where we would just do that for amphetamine and methamphetamine, and then say QC1, all those other drugs would be not there. And then QC2, they would be there because now we have a positive and a negative QC to show that. So I would have to run that by the director as well to see and kind of, yeah. It looks like he has some of them that are just present versus. 6:57 - Andrew Hartmann (UTAK Laboratories) Present is just reference values. So that means the lab that we sent it to couldn't quantitate it, but they could just confirm that it's there. Right, right. Okay. So when we go custom, that is going to be one change is you'll no longer see verified values. You'll just see the gravimetric values. Okay. It's kind of expensive to send it out for third party. So unless it's like absolutely required, it really drives up the cost. So 95% of our customers doing customs don't do the verified results. Yeah. 7:25 - Smeal, Debra A (brownhealth.org) The only thing we would need quantitative, like I said, now at this point, and we have implemented it, is the amphetamine and methamphetamine. That's it. Everything else is kind of qualitative. So one of them could not have all those drugs and the other one could at whatever. I would probably like it somewhere between 350 and 700 just to make sure we can see them properly and not have issues with it. 7:53 - Andrew Hartmann (UTAK Laboratories) Um, but yeah, so that's kind of what I think rather than coming to a final design on this call. Let's just kind of go over the ins and outs of, like, what's possible, what we can do, and then you guys can take it back to your team, kind of discuss, and then come back and say, like, hey, this is what we're going to want. Yeah. So my first question with, you know, with this is, are you testing for all of the analytes we're currently spiking in, or is there anything that we're putting in to the stock product that you guys are not testing for? 8:23 - Smeal, Debra A (brownhealth.org) Yes, so there's more of several, yeah, so the bottom one, seguline, I don't know how you're saying that, we don't do that, the fenmetrazine, fenmetrazine, we don't do that, the one above that we also don't do, the one above that we also don't do, and then. 8:48 - Andrew Hartmann (UTAK Laboratories) So we're going to want to pull out, like, basically when we get your final drug list, we're going to want you to remove anything that you don't want, that way, you know, you're not paying for 9:00 - Smeal, Debra A (brownhealth.org) to put it in because there's no point that you're not testing for, Okay, so you're going to send me this list, and we're going to modify what we want to see in it and send it back to you to make. 9:10 - Andrew Hartmann (UTAK Laboratories) Is that correct? Yeah, I can do that. 9:12 - Smeal, Debra A (brownhealth.org) Okay, because I really would rather have the director just give me a good sign-off on this. So if you would do that, if you could send me what is currently in it, and we can highlight what we don't need, and then what, submit it to you for pricing? Exactly, yeah. 9:27 - Andrew Hartmann (UTAK Laboratories) And then, because we're making this just for you, like we said, you have full control over these concentrations. Right. So if you want to move from, like, 350 to 325, if you want to edit, you know, basically anything, you don't have to keep each of these at the same concentration. Yeah. We can do individual whatever you want. 9:45 - Smeal, Debra A (brownhealth.org) Is there a pricing difference for higher quantitation or lower? Because actually, like, in all honesty, these numbers for both QCs are at the bottom end of our... Our calibration curve, and just how these patients are actually truly quantitated. So I would like something a little more reasonable in our curve, because these are both basically below our locale, which doesn't seem – I don't find it helpful. So that's kind of like – yeah. Like how high can you guys go, basically? 10:29 - Andrew Hartmann (UTAK Laboratories) I mean, you know, it's almost the sky's the limit type thing, but like – yeah, I wouldn't go too crazy, but I just wanted to If you're being like reasonable in concentration drains, like the chance – you know, the price to move from a 350 to a 700 is typically very negligible. But if we're moving from like 350 to 3,500 or 35,000, you know, that's typically where you start to see that cost go up, because it's really – it's about how much drug we're having to use to hit that concentration. 10:55 - Smeal, Debra A (brownhealth.org) Like, instance, let's – like kind of what you were saying, let's just say let's double everything. So QC1. Like, Thank should be $700, and then QC2 would be $1,400. Yeah, I don't think that would have, like, a major impact on the pricing versus if you kept it at $350 to $700. 11:10 - Andrew Hartmann (UTAK Laboratories) But if you were to try to, like, go up to, like, a top level of cow or, you know, exceeding... Well, so our top cow is $5,000 for this. Yeah, so, like, that's kind of the... I would say that's, yeah, we don't want to go... 11:21 - Smeal, Debra A (brownhealth.org) Yeah, no, I don't think that's... But, again, closer to... So, our low cow is $1,250, made cow is $2,500, and then our top cow is $5,000. So, getting closer to that low $1,250 cow, I think, would be... And kind of like what we just said, by doubling both of those, I think, would be helpful. I would ask, you know, like I said before, every ask just is... I have to talk to the director. She thinks as well with that. But, yeah, I'm just usually not a fan with our QC not being anywhere near our actions. You know, like our actual kind of cows and stuff, it seems. Okay, so I... think what I'm hearing is that you're going to send us a menu of what we can have, and we're going to send you this, but it's not an exhaustive menu. 12:08 - Andrew Hartmann (UTAK Laboratories) So if there's drugs that we're not putting in this that you would like to see us put in, you can also include those as well. Okay. And what is the turnaround time? 12:18 - Smeal, Debra A (brownhealth.org) Like, let's say Dr. Dean is not due back for 10 days, but if in 10 days I reach out, then how much longer am I waiting for the product? 12:26 - Andrew Hartmann (UTAK Laboratories) A product like this being freeze-dried, it takes a little bit longer, so you're probably looking in the ballpark of 20 to 25 business days as, like, a worst-case scenario. Okay. 12:36 - Smeal, Debra A (brownhealth.org) So just out of craziness, she's not due back until the 1st of December, so we won't get this in-house until the 1st of January. Will we make it? No. I was just about to say, could we get those two boxes? 12:52 - Andrew Hartmann (UTAK Laboratories) Yes, I can. I'll send you over. We have updated pricing on those. I'll send that over to you, and then if you could just... Update the PO to include the actual part number and then the current pricing because that's kind of what tripped us up initially is when we were looking at this. It's like it doesn't match our part number here. It's like part number 41401 is what we'll be looking for. So I'll send pricing and part intervention. Okay. All right. 13:21 - Smeal, Debra A (brownhealth.org) Let's do that. Let's make that plan. You send that over with the new pricing. We'll order. How many did you have of each one, did you say? We have two packs right now of level two. 13:30 - Andrew Hartmann (UTAK Laboratories) So have two packs left. Okay. Yeah. 13:32 - Smeal, Debra A (brownhealth.org) Let me, I'll go under. We'll order the two packs of level two just to get us by and we'll try to get a decision by you by December so that in 20 business days, early January, we have the product in house. Perfect. 13:46 - Andrew Hartmann (UTAK Laboratories) And then you can also make additional changes if it would suit you. So for a freeze-dried product, we can go all the way down to a 3 ml fill size or up to a 10 ml fill size. So if you wanted to make any adjustments on fill size or anything like that. Just let us know as well. Okay. Okay. That's great. 14:03 - Smeal, Debra A (brownhealth.org) Okay. All right. All right. And so now I'm going to just tell you who to cc this email to. 14:10 - Andrew Hartmann (UTAK Laboratories) Okay. Let me see if I have that already in my communications. I think it's just you that I have. Yep. So I'm going to give you two more. All right. Go for it. Kim Paiva. P-A-I-V-A. 14:27 - Smeal, Debra A (brownhealth.org) it's Kay Paiva at Brown Health. Okay. 14:33 - Andrew Hartmann (UTAK Laboratories) And the second one would be Kyle Thibodeau. 14:37 - Smeal, Debra A (brownhealth.org) She's got a last name. Kay. So Kay, T as in Thomas, H-I, B as in boy, O, D as in David. That's it. Yep. Oh, no, that's. 14:47 - Andrew Hartmann (UTAK Laboratories) That's an X, I think. yeah. There's no X there. I don't know why that's. 14:51 - Smeal, Debra A (brownhealth.org) It's E-A-U. It's so, yeah. T-H-I-B-O-D-E-A-U.-H-O. T-H-I Should we put Adina here as well? All right. Now let's put Dr. Adina. At brownhealth. At brownhealth.org. And the next one is Dr. Adina. She would be A. Yeah, that's that one. B-E-A-D-A. No, E. Oh, B-A. I'm sorry, B-A-D-E-A. Sorry, B-A-D. There she is. There she is. There you go. And that way, everybody will see what you sent, and we can be a little more seamless in this delivery. Perfect. 15:35 - Andrew Hartmann (UTAK Laboratories) So I will type all of this up, and then I'll send you the IFU for both products, so you can kind of take a look, and then just let us know what to remove, anything you want to add, and what you want to change concentrations to. And then I'll send you over the correct part number and pricing information for both products, as well as just inventory and expiration. Inventory is first-come, first-available, with only having two. Pax, if you could get that PO. I'll it to you today. Yep, we'll write it today. Perfect. And then once I get the update from you, about three to five business days to get the quote completed and sent over. And then once you place the order, the lead time, like you said, is probably in that 20 to 25 business day range. Got it. All right. Thank you, Sarah. Yeah. Any other questions? That's great. Good for now. Yeah. Perfect. I appreciate your time. All right. Thank you. You too. Bye. Bye. Bye. Bye.